EAM Investors, LLC - VAXCYTE INC ownership

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of VAXCYTE INC
ValueSharesWeighting
Q3 2023$881,393
-70.9%
17,289
-71.4%
0.17%
-69.6%
Q2 2023$3,024,067
+61.8%
60,554
+21.4%
0.56%
+52.6%
Q1 2023$1,868,865
-39.9%
49,863
-23.1%
0.37%
-42.9%
Q4 2022$3,108,35964,8250.64%
Other shareholders
VAXCYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 1,049,893$53,523,54517.09%
Pivotal bioVenture Partners Investment Advisor LLC 793,036$40,429,12816.12%
Kynam Capital Management, LP 1,302,407$66,396,70910.86%
RA Capital Management 7,891,254$402,296,1297.92%
COMMODORE CAPITAL LP 1,100,000$56,078,0006.56%
GREAT POINT PARTNERS LLC 531,211$27,081,1374.93%
ACUTA CAPITAL PARTNERS, LLC 121,022$6,169,7024.14%
Frazier Life Sciences Management, L.P. 1,164,405$59,361,3673.94%
Novo Holdings A/S 845,000$43,078,1003.18%
BRAIDWELL LP 1,619,553$82,564,8122.61%
View complete list of VAXCYTE INC shareholders